Liver cancer is a lethal disease with less than 1 in 4 people surviving beyond five years post diagnosis. Ground-breaking research could transform treatment options and improve survival rates.
👉 Please donate today: ow.ly/jTt350Z0VSU
These results provide initial evidence that LLMs have begun to reshape scientific production, challenging our assumptions about research quality and communication. With this, science policy must consider how institutions could evolve. [8/n]
Save the dates!
Announcing the 1st ASTRA meeting, an APAC-wide pan-cancer spatial alliance to uncover oncofetal biology.
📅19–21 Nov 2025 | In person
⛰️ Rydges Resort, Hunter Valley NSW
Rego: astraconference2025.floktu.c…
I am very proud to be part of the amazing team of researchers, scientists and clinicians who are all co-authors of the important research publication just released in Nature Medicine. The paper documents changes in my brain tumour & blood before and after I received neoadjuvant systemic combination immunotherapy treatment, which occurred in 2023.
Everyone involved, including lead authors Georgina Long and Helen Rizos, used their expertise, knowledge and creative intellect to generate this important data just released.
Whilst the paper deals with the data from just one patient (me), ultimately a clinical trial of a large group of patients needs to be conducted to determine whether or not neoadjuvant (pretreatment) combination immunotherapy is clinically effective in (a subgroup of) brain cancer patients. I hope such a trial begins in the not too distant future.
Congratulations to everyone who has contributed to this research. What a fantastic achievement!
But this is only the beginning & much more research is required to improve treatment and outcomes and ultimately save lives.
@SydneyLHD@NthSydHealth@Sydney_Uni@COBLH#glioblastoma
Garvan researchers will lead a project to map 2,000 cancer samples, aiming to understand why treatments vary across patients and cancer types. This initiative involves one of the largest collaborative cancer studies between Australia and Japan.
ow.ly/bLcu50UZTPM
Five months into new gig! Here we are building world class team in Oncofetal research at @GarvanInstitute ! We are looking for a computational biologist with proven track record in spatial biology, if you are keen to explore neighbourhoods drop a text :)
We are delighted to announce Prof Stuart Tangye, Head of the Immunology and Immunodeficiency Lab at Garvan, has been listed as a finalist for the prestigious 2024 Eureka Prize for Scientific Research! Find out more: ow.ly/WzqN50SNOVO@eurekaprizes#EurekaPrizes
Beautiful work in @SciImmunology on ‘Spatio-temporal’ dynamics of tumour associated macrophage in cancer by @DunsmoreGarett@FGinhoux
Great to collaborate with this wonderful team on important aspect of TAMs with implications therapeutic intervention science.org/doi/10.1126/scii…
Come join us at the at the Oncofetal Ecosystem lab in vibrant Sydney. Reach out if you are interested in clinical research employing the leading single cell and spatial technologies in liver cancer
I’m looking for a postdoc/research scientist to lead a phase-IIb clinical trial project (funded by NHMRC and Pharma), suitable for someone with experience in single cell and spatial biology. Please reach out if you are keen to discuss more via DM or email. #itstimetotakespatialinclinic
We are pleased to welcome to our Faculty Dr Ankur Sharma, who brings with him a leading expertise in cancer biology and an existing program of clinical translation.
@asharmaiisc
Find out more on Dr Sharma: ow.ly/ftQT50Sv6kL
A fascinating talk by Dr Eric Green @NHGRI_Director at @GarvanInstitute taking us through the length and breadth of the Genomics revolution and talking about challenges and opportunities which lies ahead
Welcome Ankur Sharma, PhD as our new Senior Editor of Emerging Technologies and Data Science. Celebrated for his groundbreaking discovery of the oncofetal ecosystem in #livercancer, he's a leading expert in single-cell genomics and spatial transcriptomics. @asharmaiisc
#newbegining I'm very excited to announce my move @GarvanInstitute after ~3.5 years in Perth. It's time to move closer to my collaborative network in beautiful and bustling Sydney. I couldn't have imagined a better place for my science & intellectual quest than Garvan, Australia's powerhouse of Genomics, Cancer & Immunology